SB-681323 In Subjects With Rheumatoid Arthritis

GSK Investigational Site, Lillehammer

GSK Investigational Site, Hvidovre

GSK Investigational Site, Mérida

GSK Investigational Site, A Coruña

GSK Investigational Site, Santiago de Compostela

GSK Investigational Site, Granada

GSK Investigational Site, Schwerin

GSK Investigational Site, Hamburg

GSK Investigational Site, Hamburg

GSK Investigational Site, Lübeck

GSK Investigational Site, Kiel

GSK Investigational Site, Madrid

GSK Investigational Site, Seville

GSK Investigational Site, Valencia

GSK Investigational Site, Baracaldo/Vizcaya

GSK Investigational Site, Pisa

GSK Investigational Site, Jesi (AN)

GSK Investigational Site, Frankfurt am Main

GSK Investigational Site, Hofheim

GSK Investigational Site, Foggia

GSK Investigational Site, Benevento

GSK Investigational Site, Telese Terme (BN)

GSK Investigational Site, Augsburg

GSK Investigational Site, Halle

GSK Investigational Site, Shatin

GSK Investigational Site, Drammen

GSK Investigational Site, Oslo

GSK Investigational Site, Oslo

GSK Investigational Site, Sarpsborg

GSK Investigational Site, Stavanger

GSK Investigational Site, Tønsberg

GSK Investigational Site, Grudziądz

GSK Investigational Site, Warsaw

GSK Investigational Site, Wroclaw

GSK Investigational Site, Gothenburg

GSK Investigational Site, Luleå

GSK Investigational Site, Wigan

GSK Investigational Site, Metropolitan Borough of Wirral

GSK Investigational Site, Edinburgh

GSK Investigational Site, London

GSK Investigational Site, Sheffield